Arnold Jonathan 4
4 · Catalent, Inc. · Filed Aug 26, 2022
Insider Transaction Report
Form 4
Catalent, Inc.CTLT
Arnold Jonathan
President, Oral Drug Delivery
Transactions
- Sale
Common Stock
2022-08-25$103.04/sh−384$39,567→ 55,958 total - Award
Common Stock
2022-08-24+6,621→ 56,342 total
Footnotes (3)
- [F1]Received upon the achievement of the fiscal 2020-22 performance-based vesting criteria set forth in certain incentive compensation held by the reporting person under the Issuer's long-term incentive plan.
- [F2]Includes restricted stock units.
- [F3]Shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of performance share units received pursuant to the Issuer's long-term incentive plan. No shares were withheld by or surrendered to the Issuer.